Evidence map›Paper›PMID 24441647›Full record

ReviewJournal of biomolecular screening2014

An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines.

Andrea de Souza, Joshua A Bittker, David L Lahr, Steve Brudz, Simon Chatwin, Tudor I Oprea, Anna Waller, Jeremy J Yang, Noel Southall, Rajarshi Guha and 6 more

Abstract readReview
In one paragraph

Review in Journal of biomolecular screening, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. ChemProt-3.0: a global chemical biology diseases mapping.Database : the journal of biological databases and curation · 2016
    Article
  3. Badapple: promiscuity patterns from noisy evidence.Journal of cheminformatics · 2016
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Andrea de SouzaBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Joshua A BittkerBroad Institute of Harvard and MIT, Cambridge, MA, USA.
David L LahrBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Steve BrudzBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Simon ChatwinBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Tudor I OpreaUniversity of New Mexico Center for Molecular Discovery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Anna WallerUniversity of New Mexico Center for Molecular Discovery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Jeremy J YangUniversity of New Mexico Center for Molecular Discovery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Noel SouthallNIH Center for Advancing Translational Sciences, Rockville, MD, USA.
Rajarshi GuhaNIH Center for Advancing Translational Sciences, Rockville, MD, USA.
Stephan C SchürerCenter for Computational Science, University of Miami, Miami, FL, USA.
Uma D VempatiCenter for Computational Science, University of Miami, Miami, FL, USA.
Mark R SouthernThe Translational Research Institute, The Scripps Research Institute, Jupiter, FL, USA.
Eric S DawsonThe Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, Vanderbilt University Medical Center, Nashville, TN, USA.
Paul A ClemonsBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Thomas D Y ChungConrad Prebys Center for Chemical Genomics, Sanford|Burnham Medical Research Institute, La Jolla, CA, USA tchung@sanfordburnham.org.

Funding

NIH Chemical Genomics CenterZIBTR000004 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MCKEW, JOHN · 2012 to 2014
$52.3M
NIH Chemical Genomics CenterZIAHG200319 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI AUSTIN, CHRISTOPHER P · 2009 to 2009
$19.9M
Yeast Biology ConsortiumU54MH084690 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI TEGOS, GEORGE P · 2008 to 2013
$14.4M
Intramural NIH HHS ZIA HG200319NIMH NIH HHS U54 MH084690
6 · The paper itself

Abstract

Recent industry-academic partnerships involve collaboration among disciplines, locations, and organizations using publicly funded "open-access" and proprietary commercial data sources. These require the effective integration of chemical and biological information from diverse data sources, which presents key informatics, personnel, and organizational challenges. The BioAssay Research Database (BARD) was conceived to address these challenges and serve as a community-wide resource and intuitive web portal for public-sector chemical-biology data. Its initial focus is to enable scientists to more effectively use the National Institutes of Health Roadmap Molecular Libraries Program (MLP) data generated from the 3-year pilot and 6-year production phases of the Molecular Libraries Probe Production Centers Network (MLPCN), which is currently in its final year. BARD evolves the current data standards through structured assay and result annotations that leverage BioAssay Ontology and other industry-standard ontologies, and a core hierarchy of assay definition terms and data standards defined specifically for small-molecule assay data. We initially focused on migrating the highest-value MLP data into BARD and bringing it up to this new standard. We review the technical and organizational challenges overcome by the interdisciplinary BARD team, veterans of public- and private-sector data-integration projects, who are collaborating to describe (functional specifications), design (technical specifications), and implement this next-generation software solution.

Indexed as

Databases, ChemicalAccess to InformationBiochemistryChemistry, PharmaceuticalData CollectionDrug DiscoveryDrug IndustryInternetNational Institutes of Health (U.S.)Small Molecule LibrariesSoftwareUnited StatesSmall Molecule LibrariesChemical biological database standardsvisualizationweb portal

Identifiers

PMID24441647
PMCPMC4468040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.